Pancreatic Diseases
Conditions
Keywords
Pancreatic cyst, Acute pancreatitis, chronic pancreatitis, Intra Pancreatic Mucinous Neoplasia, diagnosis
Brief summary
This study is a prospective cohort dedicated to pancreatic diseases excluding cancer. The aim is to develop positive or differential diagnostic tools between benign potentially malignant or malignant pancreatic pathologies. During this study the investigators collect data and biological samples to support research project.
Detailed description
This collection focuses on pathology of the pancreas requiring specific investigations or management for diagnosis or treatment. Pancreatic pathologies can be classified as malignant, potentially malignant or benign tumors. These can be solid or cystic. There is an inflammatory attack on the pancreas, generating acute pancreatitis in the acute period, if the inflammatory manifestations persist, chronic pancreatitis will develop. Some lesions may be at risk of malignancy during their evolution, it is therefore necessary to improve the performance of monitoring and diagnostic tools in order to adapt the management of patients.
Interventions
None listed
Sponsors
University Hospital, Toulouse
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* Patients with inflammatory or cystic exocrine pancreatic pathology * Patient able to read and understand the information leaflet * Patients who have agreed to participate in the study and have signed the free and informed consent * Patients affiliated to a social security system (including AME)
Exclusion criteria
* Patient with pancreatic cancer pathology * Patients with active cancer, whatever the origin * Pregnant or breastfeeding patients * Patients under legal protection, guardianship or trusteeship
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Diagnostic tools | 3 years after the first inclusion | To develop positive or differential diagnostic tools between benign potentially malignant or malignant pancreatic pathologies |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| New targets | 3 years after the first inclusion | To identify new screening targets |
| Improvement of management | 3 years after the first inclusion | To improve the management of cystic lesions or Chronic pancreatitis on the decision of therapeutic management |
| Microbiota | 3 years after the first inclusion | Study of the microbiota of pancreatic diseases |
| Clinical data access | 3 years after the first inclusion | To make available to the scientific community quality material with associated clinical data also of quality |
Countries
France
Contacts
Primary ContactBarbara BOURNET, MD
Backup ContactCindy CANIVET
Outcome results
None listed